Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab + Chemoradiation with or without Induction Chemotherapy in High Risk Locally Advanced Cervical Cancer
NCT07061977Phase 3Recruiting
- Sponsor
- National Cancer Institute
- Start
- Nov 2025
- Primary completion
- Dec 2030
- Countries
- 2
01
Overview
A Phase 3 trial of pembrolizumab, carboplatin, Paclitaxel Micelles for Injection in Cervical Cancer (CC), sponsored by National Cancer Institute. Started Nov 2025; status: recruiting.
02
Drugs
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07061977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07061977.